| Literature DB >> 35932446 |
Andreea-Alexandra Rus1, Cristian Mornoş2.
Abstract
PURPOSE OF REVIEW: Several studies have found that air pollution and climate change can have an impact on acute coronary syndromes (ACS), the leading cause of death worldwide. We synthesized the latest information about the impact of air pollution and climate change on ACS, the latest data about the pathophysiological mechanisms of meteorological factors and atmospheric pollutants on atherosclerotic disease, and an overall image of air pollution and coronary heart disease in the context of the COVID-19 pandemic. RECENTEntities:
Keywords: Acute coronary syndrome; Air pollutants; Coronary heart disease; Meteorological factors; Risk factors
Mesh:
Substances:
Year: 2022 PMID: 35932446 PMCID: PMC9361940 DOI: 10.1007/s11886-022-01759-5
Source DB: PubMed Journal: Curr Cardiol Rep ISSN: 1523-3782 Impact factor: 3.955
Main studies that analyze the role of seasonal variations and meteorological factors on acute coronary syndrome
| Quebec (Canada)/continental climate | 1981–2014 | Patients with MI | Winter | Quantity and duration of snowfall | |
| US cities/temperate climate | 1994–1996 | Patients with AMI | Winter | ||
| Canada cities/continental climate | 1980–1982 1990–1992 | Patients with AMI and Stroke | Winter | ||
| Northern France/temperate climate | 1985–1994 | Patients with MI | Winter | ||
| Waikato (New Zealand)/temperate climate | 1998–2007 | Patients with STEMI | Winter | ||
| Takashima County, Shiga (Japan)/temperate climate | 1998–2003 | Patients with AMI | Winter, Spring | ||
| England and Wales/temperate climate | 1997–2005 | Patients with AMI | Winter | ||
| Lisbon and Oporto, (Portugal)/Mediterranean climate | 2003–2007 | Patients with AMI | Winter | ||
| Athens (Greece)/Mediterranean climate | 2001 | Patients with AMI | Winter | ||
| Sao Paulo (Brazil)/subtropical climate | 1996–1997 | Patients with MI | Winter | ||
| Japan/ temperate climate | 2011–2012 | Patients with STEMI | Winter | ||
| Oita (Japan)/humid subtropical climate | 2012–2013 | Patients with AMI | Summer | ||
| Augsburg (Germany)/oceanic climate | 1987–2014 | Patients with MI | Summer | ||
| Crete Island (Greece)/Mediterranean climate | 2004–2007 | Patients with ACS | Summer | ||
| Worcester (USA)/humid continental climate | 1995, 1997, 1999 2001, 2003 | Patients with AMI | Cold months Warm months | ||
| Different regions of Italy with different types of climate | 2012–2017 | Patients with STEMI | Winter ( Spring (greater variations in ATM, Summer ( | ||
| Jerusalem (Israel)/Mediterranean climate | 2001–2005 | Patients with AMI | Winter | ||
ACS acute coronary syndrome, MI myocardial infarction, AMI acute myocardial infarction, STEMI ST-elevation myocardial infarction, ATM atmospheric pressure, CHD coronary heart disease, CVD cardiovascular disease, Tapp daily 3-h maximum apparent temperature
aA linear association between air temperature and ACS admissions
bA V-shaped relation between atmospheric pressure and MI: ↑/↓ atmospheric pressure over/below 1016 mbar ↑ risk of MI
cA U-shaped relation between ambient temperature and CHD mortality: ↑/↓ air temperature over/below 26–29 °C ↑ CHD mortality
dA U-shaped relation between ambient temperature and ACS admissions: ↑/↓ air temperature over/below 27–29 °C ↑ ACS admissions
eAn inverse J-shaped relation between ambient temperature and ACS admissions: ↑/↓ air temperature over/below temperature threshold (25 °C) ↑ ACS admissions
Fig. 1Pathophysiological mechanisms of meteorological factors and air pollutants on acute coronary syndrome. a Pathophysiological mechanisms of meteorological factors. b Pathophysiological mechanisms of air pollutants
Main studies that analyze the role of air pollutants on cardiovascular disease, especially on acute coronary syndrome
| USA | 1982, follow-up 16 years | Random samples of adults | PM, sulfate, NO2, SO2, O3, CO | PM, sulfate | ||
| England and Wales | 2004–2007, average follow-up 3.7 years | Patients with ACS | PM10, PM2.5, NO2, NOX | PM2.5 | ||
| Germany, Finland, Denmark, Sweden, and Italy | 1997–2007, average follow-up 11.5 years | Patients with ACS | PM10, PM2.5, NO2, NOX | PM10, PM2.5 | ||
| England and Wales | 2003–2006 | Patients with MI | PM10, NO2, SO2, O3, CO | PM10, NO2 | ||
| England and Wales | 2003–2010 | Patients with STEMI, NSTEMI | PM10, PM2.5, NO2, O3 | NO2 | ||
| Alberta (Canada) | 1999–2010 | Patients with STEMI, NSTEMI | PM2.5, NO2, O3, NO, CO | NO2 | ||
| Strasbourg (France) | 2012–2014 | Patients with coronary events | PM10, PM2.5, NO2 | NO2 | ||
| Stockholm (Sweden) | 2000–2014 | Patients with MI | PM10, PM2.5, NO2, SO2, O3 | NO2 | ||
| Rome (Italy) | 2001–2005 | Patients with CVD | PM10, PM2.5, UFP | PM10, PM2.5 | ||
| Beijing (China) | 2013–2017 | Patients with CVD | PM2.5, NO2, SO2, O3, CO | PM2.5 | ||
| Rochester (New York) | 2007–2010 | Patients with STEMI, NSTEMI | PM2.5, UFP | PM2.5 | ||
| Bialystok (Poland) | 2008–2017 | Patients with ACS | PM10, PM2.5, NO2, SO2 | PM10 | ||
| Poland | 2008–2017 | Patients with ACS | PM10, PM2.5, NO2, SO2, CO | PM10, PM2.5, NO2, SO2, CO | ||
| Belgia | 2009–2013 | Patients with STEMI | PM10, PM2.5, NO2, O3 | PM10, PM2.5, NO2, | ||
| Toulouse (France) | 1997–1999 | Patients with AMI | NO2, SO2, O3 | O3 | ||
ACS acute coronary syndrome, PM particulate matter, NO nitrogen dioxide, SO sulfur dioxide, O ozone, CO carbon monoxide, PM particulate matter with an aerodynamic diameter ≤ 10 μm, PM particulate matter with an aerodynamic diameter ≤ 2.5 μm, NO nitrogen oxides, MI myocardial infarction, STEMI ST-elevation myocardial infarction, NSTEMI non-ST-elevation myocardial infarction, NO nitrogen monoxide, CVD cardiovascular disease, UFP ultrafine particles